BIO-key International
BKYI
10 hedge funds and large institutions have $186K invested in BIO-key International in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
10% more capital invested
Capital invested by funds: $169K → $186K (+$17.3K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% less ownership
Funds ownership: 0.02% → 0.01% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$7.18K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.26K |
| 3 |
JP Morgan Chase
New York
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$798 |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$532 |
BKYI Hedge Fund Activity: Q2 2023 in Review
10 institutional investors reported a position in BIO-key International (BKYI) for Q2 2023, worth a combined $186K — up 10% from $169K a quarter earlier.
Fund positioning in BKYI was balanced in Q2 2023: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $7.18K. The largest seller was HRT Financial, exiting entirely with an estimated $9K sold.
- 10 institutional investors held BIO-key International (BKYI) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $186K of BIO-key International stock for Q2 2023, up 10% quarter-over-quarter.
- 3 funds opened new BIO-key International positions in Q2 2023 and 3 closed out, a net change of 0 holders.
- The largest BIO-key International buyer in Q2 2023 was Citadel Advisors, an estimated $7.18K added.
- The largest BIO-key International seller in Q2 2023 was HRT Financial, an estimated $9K sold.
Based on aggregated 13F filings for Q2 2023.